Starling Oncology, Inc. Derivative Liability, Noncurrent
Starling Oncology, Inc. (STLN) had Derivative Liability, Noncurrent of $10.84 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DerivativeLiabilitiesNoncurrent · last filed 2026-08-06
- 2026-06-30: Derivative Liability, Noncurrent $10.84M.
- 2026-03-31: Derivative Liability, Noncurrent $7.59M.
- 2025-12-31: Derivative Liability, Noncurrent $12.59M.
- 2025-09-30: Derivative Liability, Noncurrent $13.66M.
| Period end | Derivative Liability, Noncurrent | Derivative Liability, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $10.84M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $7.59M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $12.59M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $13.66M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $7.68M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $3.69M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $385.00K 10-K · filed 2026-03-12 | |
| 2024-09-30 | $514.00K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $514.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $3.08M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $3.08M 10-K · filed 2025-03-26 | |
| 2023-09-30 | $1.93M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $642.00K 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $642.00K 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $3.96M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $12.65M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $9.78M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $20.58M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-16 | $60.02M 10-K · filed 2022-03-11 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-11 |